BBS-Bioactive Bone Substitutes Oyj (BONEH) - Cash Flow Conversion Efficiency

Latest as of June 2024: -0.416x

Based on the latest financial reports, BBS-Bioactive Bone Substitutes Oyj (BONEH) has a cash flow conversion efficiency ratio of -0.416x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.58 Million ≈ $-1.84 Million USD) by net assets (€3.79 Million ≈ $4.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BBS-Bioactive Bone Substitutes Oyj - Cash Flow Conversion Efficiency Trend (2015–2023)

This chart illustrates how BBS-Bioactive Bone Substitutes Oyj's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BBS-Bioactive Bone Substitutes Oyj (BONEH) financial obligations for a breakdown of total debt and financial obligations.

BBS-Bioactive Bone Substitutes Oyj Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BBS-Bioactive Bone Substitutes Oyj ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fsport AB ST:FSPORT	0.215x
BioRestorative Therapies Inc NASDAQ:BRTX	-1.315x
Montanaro UK Smaller Companies Investment Trust PLC LSE:MTU	-0.009x
Yida China Holdings Ltd STU:YC2	N/A
WILDCAT PRETR.LS -000028 F:8Y6	N/A
Eurotex Industries and Exports Limited NSE:EUROTEXIND	0.047x
Scheerders van Kerchove's Verenigde fabrieken nv BR:SCHD	0.091x
Eagle Eye Solutions Group plc LSE:EYE	0.268x

Annual Cash Flow Conversion Efficiency for BBS-Bioactive Bone Substitutes Oyj (2015–2023)

The table below shows the annual cash flow conversion efficiency of BBS-Bioactive Bone Substitutes Oyj from 2015 to 2023. For the full company profile with market capitalisation and key ratios, see BONEH market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	€5.11 Million ≈ $5.97 Million	€-2.92 Million ≈ $-3.42 Million	-0.572x	+13.21%
2022-12-31	€4.27 Million ≈ $4.99 Million	€-2.82 Million ≈ $-3.29 Million	-0.659x	+4.93%
2021-12-31	€3.63 Million ≈ $4.25 Million	€-2.52 Million ≈ $-2.95 Million	-0.693x	-74.58%
2020-12-31	€6.09 Million ≈ $7.12 Million	€-2.42 Million ≈ $-2.83 Million	-0.397x	+15.30%
2019-12-31	€3.08 Million ≈ $3.60 Million	€-1.44 Million ≈ $-1.69 Million	-0.469x	-21.77%
2018-12-31	€4.42 Million ≈ $5.16 Million	€-1.70 Million ≈ $-1.99 Million	-0.385x	+61.34%
2017-12-31	€1.08 Million ≈ $1.26 Million	€-1.08 Million ≈ $-1.26 Million	-0.996x	-738.64%
2016-12-31	€4.60 Million ≈ $5.37 Million	€-546.00K ≈ $-638.33K	-0.119x	-23.33%
2015-12-31	€4.46 Million ≈ $5.22 Million	€-430.00K ≈ $-502.72K	-0.096x	--

About BBS-Bioactive Bone Substitutes Oyj

HE:BONEH Finland Medical Devices

Market Cap

$1.76 Million

€1.50 Million EUR

Market Cap Rank

#30127 Global

#150 in Finland

Share Price

€0.05

Change (1 day)

+0.00%

52-Week Range

€0.05 - €0.05

All Time High

€9.68